Exploring ProAssurance Corporation (PRA) Investor Profile: Who’s Buying and Why?

Have you ever wondered who the major players are behind ProAssurance Corporation (PRA) and what drives their investment decisions? As of April 17, 2025, the stock price closed at $23.19, reflecting a dynamic market influenced by both institutional and individual investors. Institutional ownership stands at 84.91%, with the top 10 institutional holders accounting for 56.82% of the shares outstanding. BlackRock Inc. holds the largest position with 7.47 million shares, valued at approximately $173.27 million as of December 31, 2024. Vanguard Group Inc. follows with 5.73 million shares, valued at $132.82 million. T. Rowe Price Investment Management, Inc. holds 4.06 million shares, valued at $94.19 million. With such significant institutional interest, understanding these investors' profiles and motivations can provide valuable insights into the stock's potential and stability. Dive in to explore who these key stakeholders are and why they're investing in ProAssurance.

ProAssurance Corporation (PRA) Who Invests in ProAssurance Corporation (PRA) and Why?

Understanding the investor profile of ProAssurance Corporation (PRA) involves examining the diverse range of entities and individuals that hold its stock, along with their motivations for investing. This analysis encompasses key investor types, their investment strategies, and the factors that attract them to ProAssurance Corporation (PRA).

Key investor types in ProAssurance Corporation (PRA) typically include:

• Retail Investors: Individual investors who buy shares for their personal accounts.
• Institutional Investors: Entities such as mutual funds, pension funds, insurance companies, and investment banks that invest on behalf of their clients.
• Hedge Funds: Investment partnerships that use pooled funds and employ various strategies to earn active return, or alpha, for their investors.

Investment motivations for investing in ProAssurance Corporation (PRA) can vary based on the investor type, but commonly include:

• Growth Prospects: Investors may be attracted to ProAssurance Corporation (PRA)'s potential for growth in the specialty insurance market, particularly in the healthcare sector.
• Dividends: Companies that consistently pay dividends, like ProAssurance Corporation (PRA), can be attractive to income-seeking investors.
• Market Position: A strong market position in a niche area of the insurance industry can make ProAssurance Corporation (PRA) an appealing investment.

Typical investment strategies seen among investors in ProAssurance Corporation (PRA) are:

• Long-Term Holding: Many institutional investors adopt a long-term holding strategy, based on the company's stability and consistent performance.
• Value Investing: Some investors may see ProAssurance Corporation (PRA) as undervalued, leading them to invest with the expectation that the market will recognize its intrinsic value over time.
• Short-Term Trading: Hedge funds and other active traders may engage in short-term trading strategies to capitalize on price fluctuations.

To provide a clearer picture, consider a hypothetical snapshot of ProAssurance Corporation (PRA)'s investor composition. Note that the following data is illustrative and based on general trends, not specific real-time data:

Understanding these different facets of ProAssurance Corporation (PRA)'s investor profile provides insight into the market's perception of the company and the diverse factors influencing its stock performance. For more insights into ProAssurance Corporation's values, see: Mission Statement, Vision, & Core Values of ProAssurance Corporation (PRA).

ProAssurance Corporation (PRA) Institutional Ownership and Major Shareholders of ProAssurance Corporation (PRA)

Institutional ownership in ProAssurance Corporation (PRA) reflects a significant portion of the company's shares being held by various institutions. As of December 31, 2024, institutional investors held approximately 84.91% of ProAssurance Corporation’s shares.

Here's a breakdown of the key aspects of institutional ownership in ProAssurance Corporation (PRA):

• Total Institutional Holders: There are 421 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC), holding a total of 56,271,320 shares.
• Shares Outstanding: ProAssurance Corporation has 51,156,821 shares outstanding.
• Float: The percentage of shares available to trade (float) is 98.65%.
• Mutual Fund Ownership: Mutual funds hold approximately 55.94% of the company's shares.
• Insider Ownership: Insiders own about 1.3% of the company.
• Top 10 Institutional Holders: The top 10 institutional holders own 56.82% of the company.

Here are the top institutional investors in ProAssurance Corporation (PRA) as of December 31, 2024:

• BlackRock, Inc.: 7,471,792 shares, representing 14.61% of outstanding shares, valued at $174,541,061.
• The Vanguard Group, Inc.: 5,727,580 shares, representing 11.2% of outstanding shares, valued at $133,796,269.
• T. Rowe Price Group, Inc.: 4,110,749 shares, representing 8.04% of outstanding shares, valued at $96,027,097.
• Wellington Management Group LLP: 2,987,196 shares, representing 5.84% of outstanding shares, valued at $69,780,899.
• Dimensional Fund Advisors LP: 2,703,953 shares, representing 5.29% of outstanding shares, valued at $63,164,342.
• State Street Global Advisors, Inc.: 2,021,765 shares, representing 3.95% of outstanding shares, valued at $47,228,430.
• Allspring Global Investments, LLC: 1,316,249 shares, representing 2.57% of outstanding shares, valued at $30,747,577.
• Geode Capital Management, LLC: 1,162,533 shares, representing 2.27% of outstanding shares, valued at $27,156,771.
• Columbia Management Investment Advisers, LLC: 868,074 shares, representing 1.7% of outstanding shares, valued at $20,278,209.
• Arrowstreet Capital, Limited Partnership: 690,871 shares, representing 1.35% of outstanding shares, valued at $16,138,747.

Recent changes in ownership have shown a mix of increased and decreased positions by institutional investors. Examining these shifts can provide insights into investor sentiment and potential future stock performance.

Here's an overview of recent ownership activity:

• New Positions: 22 holders acquired 651,861 new shares.
• Increased Positions: 63 holders increased their positions by 1,998,850 shares.
• Decreased Positions: 88 holders decreased their positions by 2,775,905 shares.
• Sold Out Positions: 19 holders sold out their entire positions, totaling 339,491 shares.
• Net Change: Overall, there was a net decrease of 125,194 shares held by institutional investors.

Institutional investors play a crucial role in shaping a company's stock price and influencing its strategic direction. Their investment decisions can drive trading volumes and impact market sentiment. High institutional ownership often lends stability to a stock, but significant changes in their positions can lead to volatility.

Understanding the composition and changes in institutional ownership can provide valuable insights for investors. Monitoring these trends can help assess the overall health and prospects of ProAssurance Corporation (PRA) and make informed investment decisions.

To gain more insights into ProAssurance Corporation (PRA), you might find this resource helpful: ProAssurance Corporation (PRA): History, Ownership, Mission, How It Works & Makes Money

ProAssurance Corporation (PRA) Key Investors and Their Impact on ProAssurance Corporation (PRA)

Understanding the investor profile of ProAssurance Corporation (PRA) provides valuable insights into the company's stability, strategic direction, and potential stock performance. Key investors can significantly influence company decisions and stock movements through their holdings and actions.

While specific real-time data on all individual investors might fluctuate, examining institutional ownership, major shareholders, and recent trading activities offers a comprehensive view. Institutional investors, such as mutual funds, pension funds, and hedge funds, often hold substantial stakes in ProAssurance Corporation (PRA). These institutions conduct thorough research before investing, and their actions can signal confidence or concern about the company's prospects.

Here are some factors to consider regarding ProAssurance Corporation (PRA)'s investors:

• Notable Investors: Identifying key institutional investors with significant holdings is crucial. These may include well-known funds that specialize in the financial or insurance sectors.
• Investor Influence: Large institutional investors can exert influence on company management through voting rights and direct engagement. Their views on corporate governance, strategic direction, and executive compensation can shape company policy.
• Recent Moves: Monitoring recent buying or selling activity by major investors can provide clues about their sentiment regarding ProAssurance Corporation (PRA)'s future performance. Significant stake increases might indicate optimism, while large sell-offs could signal concerns.

Information on major shareholders and institutional holdings can often be found in the company's annual reports, proxy statements, and filings with the Securities and Exchange Commission (SEC). Financial news outlets and data providers also track institutional ownership and trading activity.

For example, let's consider a hypothetical scenario based on typical investor behavior:

Keeping an eye on these dynamics helps investors understand the broader context surrounding ProAssurance Corporation (PRA)'s stock and make more informed decisions.

Further insights into ProAssurance Corporation (PRA)'s financial standing can be found here: Breaking Down ProAssurance Corporation (PRA) Financial Health: Key Insights for Investors

ProAssurance Corporation (PRA) Market Impact and Investor Sentiment

Understanding investor sentiment and market reactions is crucial for evaluating the potential future of ProAssurance Corporation. Recent events, particularly the announcement of the acquisition by The Doctors Company, have significantly influenced both investor behavior and analyst perspectives. This chapter will explore these dynamics, providing a comprehensive overview of the current market landscape for ProAssurance.

On March 19, 2025, The Doctors Company, the largest physician-owned medical malpractice insurer, announced it would acquire ProAssurance for $25.00 per share in cash. This deal values ProAssurance at approximately $1.3 billion, representing a 60% premium over ProAssurance's closing price on March 18, 2025. The combined entity will have assets of approximately $12 billion. The transaction, unanimously approved by ProAssurance's Board of Directors, is expected to close in the first half of 2026, subject to shareholder and regulatory approvals. Upon completion, ProAssurance will become a wholly-owned subsidiary of The Doctors Company and will be delisted from the NYSE.

The announcement of the acquisition has had a notable impact on the stock market's reaction to ProAssurance. The stock is trading near its 52-week high of $23.70, having delivered a 72% return over the past year. The share price of ProAssurance Corporation stock closed at $23.19 as of April 17, 2025. The 52-week high is $23.68 and the 52-week low is $10.76.

Here’s a breakdown of how major shareholders currently view ProAssurance:

• Institutional Ownership: Approximately 83.42% of ProAssurance is held by institutional shareholders.
• Insider Ownership: Insiders own about 12.89% of the company.
• Retail Investors: Retail investors hold approximately 3.68%.

Some of the top institutional holders include:

• BlackRock Inc.: Holds 7,471,792 shares, representing 14.61% of the company, valued at approximately $174.09 million as of December 31, 2024.
• The Vanguard Group, Inc.: Holds 5,727,580 shares, representing 11.20%, valued at $133.45 million.
• T. Rowe Price Investment Management, Inc.: Holds 4,061,594 shares, representing 7.94%, valued at $94.64 million.

Analyst perspectives on ProAssurance are varied, reflecting the complexities of the company's current position. According to a consensus of 8 analysts, the stock has a 'Hold' rating. As of April 18, 2025:

• 0% of analysts recommend a 'Strong Buy'.
• 38% recommend a 'Buy'.
• 63% suggest 'Holding'.
• 0% advise 'Selling'.
• 0% predict a 'Strong Sell'.

The average one-year price target for ProAssurance is $20.66 per share as of April 2, 2025, which represents an 11.66% decrease from its latest reported closing price of $23.38. However, it's important to note that analyst ratings and price targets are subject to change, especially in light of the pending acquisition.

Recent news indicates some analysts are adjusting their ratings. For example, on April 3, 2025, Citizens Capital Markets downgraded ProAssurance from 'Market Outperform' to 'Market Perform'. Conversely, other analysts have increased their price targets, with one firm increasing its target by 14% to $20.25 in March 2025.

ProAssurance has a relatively low level of analyst coverage. Analyst opinions and estimates should be regarded as theirs alone and do not represent opinions, forecasts or predictions of ProAssurance Corporation or its management.

Here is a summary of ProAssurance's financial performance for the full year 2024:

• Net income of $52.7 million, or $1.03 per diluted share.
• Operating income of $48.6 million, or $0.95 per diluted share.

For the three months ended December 31, 2024, the company reported:

• Net income of $16.2 million, or $0.31 per diluted share.
• Operating income of $18.3 million, or $0.36 per diluted share.

These figures reflect the company's ongoing efforts to improve profitability and efficiency.

The acquisition by The Doctors Company is expected to close in the first half of 2026, pending regulatory approval. This transaction combines the second and fourth-largest medical professional liability insurers in the United States. Upon completion, ProAssurance will become a wholly-owned subsidiary of The Doctors Company.

Institutional ownership remains strong, with major holders like BlackRock and The Vanguard Group maintaining significant positions. However, recent trading activity indicates some shifts in institutional holdings. For example, T. Rowe Price Investment Management decreased its holdings by 12.61% in the last quarter.

Overall, investor sentiment towards ProAssurance is currently influenced by the pending acquisition. While some analysts express concerns about valuation, the acquisition price offers a substantial premium to shareholders. The company's financial performance in 2024 shows signs of improvement, but the long-term impact of the acquisition remains to be seen.

For further insights into ProAssurance's financial health, you can explore this resource: Breaking Down ProAssurance Corporation (PRA) Financial Health: Key Insights for Investors